Skip to main content
Fig. 6 | Cancer Nanotechnology

Fig. 6

From: Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer

Fig. 6

Treatment with RALA/CMV-iNOS improves survival of PC3-luc2M metastases-bearing mice. a Survival of metastases-bearing mice. N ≥ 5 (control, RALA) or 11 (RALA/CMV-iNOS). b Weight loss of exemplar mice. c Total bioluminescence in exemplar mice; inverted triangles denote treatment timepoints. d IVIS images of mice (control and RALA/CMV-iNOS) showing bioluminescence accumulation at indicated timepoints post-implantation

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us